National Institute of Allergy and Infectious Diseases



	Advanced Search

Genome Sequencing Centers
Overview
Eligibility Criteria
Assurance to Users
Application Process
Request Process
User Requirements
Prioritization and Approval Process
News and Announcements
Related Programs
Data Release Policies
Influenza Genome Sequencing Project
Pathogen and Vector Sequencing Project

Genome Sequencing Centers

Request Process

White Paper Application

NIAID will only accept and review white papers to sequence and genotype microorganisms, their hosts or their invertebrate vector of infectious diseases that are considered agents of bioterrorism or cause emerging or re-emerging infectious diseases and related strains or species. Comparative genomics sequencing projects are encouraged that are not hypothesis driven projects, predominately DNA sequencing and generate genomic data for the broad scientific community.

Submitting White Papers

An individual investigator or a collaborative group of investigators interested in requesting DNA sequencing, primary annotation analysis and or genotyping of a specific microorganism, group of microorganisms, or an invertebrate vector of infectious disease must submit a "white paper" (Word) to NIAID for consideration. A white paper template is available that spells out all components that to be addressed in order for the white paper to be reviewed.The paper must describe the sequencing project, its importance, and its readiness to be sequenced.

An investigator or group of investigators submitting a white paper is/are encouraged to contact one of the NIAID Genome Sequencing Centers (GSCs) for assistance in preparing the white paper. Contact by e-mail: the J. Craig Venter Institute, gsc@jcvi.org; The Broad Institute, gscid@broadinstitute.org; or the Institute for Genome Sciences at the University of Maryland School of Medicine, gscid-info@som.umaryland.edu. This initial contact with the NIAID GSC should not be in any way considered binding. Once NIAID reviews and selects the sequencing project, NIAID will select the GSC to perform the sequencing.
A detailed plan for sequencing the organism or group of organisms will be finalized only after selection of the organisms for sequence in consultation with the NIAID GSC and NIAID.
The white paper should not exceed ten pages and should be submitted electronically per requirements via the web site of any of the NIAID Genomic Sequencing Centers for Infectious Diseases. Include all attachments, if any, to the application.